Kidney transplant recipients receiving mTOR inhibitors experienced twice as many thrombotic events: a single cohort observational study

Thromb Res. 2014 Oct;134(4):928-30. doi: 10.1016/j.thromres.2014.08.001. Epub 2014 Aug 16.

Authors

Claudio Musetti¹, Michele Battista², Cristina Izzo², Piero Stratta²

Affiliations

¹ University of Eastern Piedmont "Amedeo Avogadro", Department of Translational Medicine, Nephrology and Kidney Transplant, Novara (NO), Italy. Electronic address: claudio.musetti@med.unipmn.it.
² University of Eastern Piedmont "Amedeo Avogadro", Department of Translational Medicine, Nephrology and Kidney Transplant, Novara (NO), Italy.

PMID: 25175361
DOI: 10.1016/j.thromres.2014.08.001

No abstract available

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Cohort Studies
Female
Humans
Immunosuppressive Agents / adverse effects*
Kidney Transplantation / adverse effects*
Male
Middle Aged
TOR Serine-Threonine Kinases / antagonists & inhibitors*
Thrombosis / chemically induced
Thrombosis / etiology*
Transplant Recipients

Substances

Immunosuppressive Agents
TOR Serine-Threonine Kinases